Skip to main content
. 2018 Jan 11;13:367–386. doi: 10.2147/IJN.S144266

Figure 4.

Figure 4

Cell viability (MTS assay) study of DCs treated for 72 hours with OV containing PLGA NP formulations (n=3).

Note: The treated OV concentration in NPs was 1 mg/mL for a cell density of 10,000.

Abbreviations: AD, adsorption; BS, bis(sulfosuccinimidyl) suberate; C, COOH-ended PLGA; COV, covalent; DCs, dendritic cells; E, ester-ended PLGA; MP, monophosphoryl lipid A; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; NP, nanoparticle; OV, ovalbumin; PLGA, poly-lactic-co-glycolide.